These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38799431)

  • 1. The fibrosis-4 index is a prognostic factor for cholangiocarcinoma patients who received immunotherapy.
    Zhang Z; Zhang J; Cai M; Huang X; Guo X; Zhu D; Guo T; Yu Y
    Front Immunol; 2024; 15():1376590. PubMed ID: 38799431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of neutrophil distribution in cholangiocarcinoma.
    Mao ZY; Zhu GQ; Xiong M; Ren L; Bai L
    World J Gastroenterol; 2015 Apr; 21(16):4961-8. PubMed ID: 25945010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z
    BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.
    Bisello S; Buwenge M; Palloni A; Autorino R; Cellini F; Macchia G; Deodato F; Cilla S; Brandi G; Tagliaferri L; Cammelli S; Valentini V; Morganti AG; Mattiucci GC
    Anticancer Res; 2019 Jun; 39(6):3095-3100. PubMed ID: 31177154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer.
    Kobayashi M; Sakabe T; Abe H; Tanii M; Takahashi H; Chiba A; Yanagida E; Shibamoto Y; Ogasawara M; Tsujitani S; Koido S; Nagai K; Shimodaira S; Okamoto M; Yonemitsu Y; Suzuki N; Nagaya M;
    J Gastrointest Surg; 2013 Sep; 17(9):1609-17. PubMed ID: 23877328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of isolated biliary candidiasis in patients with unresectable cholangiocarcinoma.
    Kim IH; Choi JK; Lee DG; Lee IS; Hong TH; You YK; Chun HJ; Lee MA
    Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):533-539. PubMed ID: 27733324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.
    Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J
    Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-based prognostic scores in patients with extrahepatic bile duct lesions treated by percutaneous transhepatic biliary stenting combined with
    Hu X; Pang Q; Liu H; Qian Z; Jin H; Zhou L; Wang Y; Man Z; Li Z; Yang S
    Clin Transl Oncol; 2019 May; 21(5):665-673. PubMed ID: 30368724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
    Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
    Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy?
    Patel SH; Kooby DA; Staley CA; Sarmiento JM; Maithel SK
    HPB (Oxford); 2011 Sep; 13(9):605-11. PubMed ID: 21843260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.
    Kuhlmann JB; Euringer W; Spangenberg HC; Breidert M; Blum HE; Harder J; Fischer R
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):437-43. PubMed ID: 22261548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External beam radiation therapy with or without concurrent chemotherapy for patients with unresectable locally advanced hilar cholangiocarcinoma.
    Chen SC; Chen MH; Li CP; Chen MH; Chang PM; Liu CY; Tzeng CH; Liu YM; Yen SH; Chao Y; Huang PI
    Hepatogastroenterology; 2015; 62(137):102-7. PubMed ID: 25911877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in patients with advanced extrahepatic cholangiocarcinoma: A single center experience.
    Aktas G; Kus T; Balkan A; Metin T; Gulsen MT; Abali H
    Medicine (Baltimore); 2019 Feb; 98(8):e14556. PubMed ID: 30813168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
    Lurje G; Bednarsch J; Czigany Z; Lurje I; Schlebusch IK; Boecker J; Meister FA; Tacke F; Roderburg C; Den Dulk M; Gaisa NT; Bruners P; Neumann UP
    Eur J Surg Oncol; 2019 Aug; 45(8):1468-1478. PubMed ID: 31053477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification and prognostic nomogram for post-recurrence overall survival in patients with recurrent extrahepatic cholangiocarcinoma.
    Kim BH; Kim K; Chie EK; Kwon J; Jang JY; Kim SW; Oh DY; Bang YJ
    HPB (Oxford); 2017 May; 19(5):421-428. PubMed ID: 28108099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in patients with advanced cholangiocarcinoma: role of surgery, chemotherapy and body mass index.
    Farhat MH; Shamseddine AI; Tawil AN; Berjawi G; Sidani C; Shamseddeen W; Barada KA
    World J Gastroenterol; 2008 May; 14(20):3224-30. PubMed ID: 18506930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin.
    Huh G; Ryu JK; Chun JW; Kim JS; Park N; Cho IR; Paik WH; Lee SH; Kim YT
    BMC Cancer; 2020 Sep; 20(1):907. PubMed ID: 32967632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemoembolization plus lenvatinib with or without a PD-1 inhibitor for advanced and metastatic intrahepatic cholangiocarcinoma: a retrospective real-world study.
    Ning Z; Xie L; Yan X; Hua Y; Shi W; Lin J; Xu L; Meng Z
    Br J Radiol; 2023 Oct; 96(1150):20230079. PubMed ID: 37660471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.